Fenofibrate may be an effective treatment option in children with hypertriglyceridemia, in whom lower levels of triglycerides ...
CLEVELAND — Fenofibrate, patented in 1969 and in medical use since 1975, is well-established as a cholesterol-lowering treatment. However, University Hospitals scientists believe it may also have the ...
Objective Diabetic patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] 30–59 mL/min/1.73 m 2) are at particular cardiovascular risk. Fenofibrate's safety in these ...
The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative 27% over 4 years compared with placebo (22.7% vs 29.2%, P=0.006), reported David Preiss, MBChB, PhD, of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results